search
Back to results

Clinical Evaluation of Two Multifocal Contact Lenses

Primary Purpose

Presbyopia

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Lens A
Lens B
Sponsored by
Coopervision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Presbyopia

Eligibility Criteria

42 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Is at least 42 years of age and has full legal capacity to volunteer.
  • Has read and signed an information consent letter.
  • Self-reports having a full eye examination in the previous two years.
  • Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Habitually wears multifocal soft contact lenses, or sphere lenses for monovision, or sphere lenses for monovision, or sphere lenses for distance vision correction and use spectacles for near vision correction, for the past 3 months minimum.
  • Has refractive astigmatism no higher than -0.75DC.
  • Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D.
  • Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deem to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS).

Exclusion Criteria:

  • Is participating in any concurrent clinical or research study.
  • Has any known active ocular disease and/or infection that contraindicates contact lens wear.
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable.
  • Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable.
  • Has known sensitivity to the diagnostic sodium fluorescein used in the study.
  • Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment.
  • Has undergone refractive error surgery or intraocular surgery.

Sites / Locations

  • School of Optometry Clinic, National Autonomous University (UNAM)

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Lens A, Then Lens B

Arm Description

Participants will wear Lens A for 15 minutes and then wear Lens B for 15 minutes.

Outcomes

Primary Outcome Measures

Subjective Comfort Ratings on Insertion
Subjective comfort ratings on insertion were measured on a scale from 0 - 10, where 0= extremely uncomfortable and 10= can't feel.

Secondary Outcome Measures

Full Information

First Posted
July 11, 2022
Last Updated
August 29, 2023
Sponsor
Coopervision, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05457608
Brief Title
Clinical Evaluation of Two Multifocal Contact Lenses
Official Title
Clinical Evaluation of Clariti Monthly Multifocal and Clariti 1 Day Multifocal
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
June 25, 2022 (Actual)
Primary Completion Date
August 13, 2022 (Actual)
Study Completion Date
August 13, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coopervision, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to evaluate the patient subjective experiences of the monthly multifocal lens when compared to the daily disposable multifocal lens after 15 minutes of daily wear.
Detailed Description
This is a single-blind, interventional, prospective, direct refit, bilateral wear study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Presbyopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
42 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lens A, Then Lens B
Arm Type
Experimental
Arm Description
Participants will wear Lens A for 15 minutes and then wear Lens B for 15 minutes.
Intervention Type
Device
Intervention Name(s)
Lens A
Intervention Description
monthly replacement multifocal silicone hydrogel contact lens 15 minutes of daily wear
Intervention Type
Device
Intervention Name(s)
Lens B
Intervention Description
daily disposable multifocal silicone hydrogel contact lens 15 minutes of daily wear
Primary Outcome Measure Information:
Title
Subjective Comfort Ratings on Insertion
Description
Subjective comfort ratings on insertion were measured on a scale from 0 - 10, where 0= extremely uncomfortable and 10= can't feel.
Time Frame
At insertion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
42 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Is at least 42 years of age and has full legal capacity to volunteer. Has read and signed an information consent letter. Self-reports having a full eye examination in the previous two years. Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week. Is willing and able to follow instructions and maintain the appointment schedule. Habitually wears multifocal soft contact lenses, or sphere lenses for monovision, or sphere lenses for monovision, or sphere lenses for distance vision correction and use spectacles for near vision correction, for the past 3 months minimum. Has refractive astigmatism no higher than -0.75DC. Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deem to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS). Exclusion Criteria: Is participating in any concurrent clinical or research study. Has any known active ocular disease and/or infection that contraindicates contact lens wear. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable. Has known sensitivity to the diagnostic sodium fluorescein used in the study. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment. Has undergone refractive error surgery or intraocular surgery.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rubén V Guerrero, MSc, FIACLE
Organizational Affiliation
School of Optometry, National Autonomous University (UNAM)
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Optometry Clinic, National Autonomous University (UNAM)
City
Mexico City
Country
Mexico

12. IPD Sharing Statement

Learn more about this trial

Clinical Evaluation of Two Multifocal Contact Lenses

We'll reach out to this number within 24 hrs